A bedside dipstick method to detect Plasmodium falciparum

Ira Shah1, C T Deshmukh

  • 1Department of Pediatrics, Seth G.S. Medical College and KEM Hospital, Parel, Mumbai-400012, India. irashah86@hotmail.com

Indian Pediatrics
|December 14, 2004
PubMed

Insights

The Parasight-F dipstick test effectively diagnoses Plasmodium falciparum malaria in children, showing 83.3% sensitivity. However, its accuracy decreases significantly in mixed infections and in infants under six months.

Area of Science:

  • Medical diagnostics
  • Parasitology
  • Pediatric infectious diseases

Background:

  • Accurate diagnosis of Plasmodium falciparum malaria is crucial for effective treatment, especially in children.
  • Rapid diagnostic tests (RDTs) offer a promising alternative to microscopy, but their performance varies.
  • The HRP-II antigen detection method is a common basis for RDTs.

Purpose of the Study:

  • To evaluate the diagnostic efficacy of the Parasight-F dipstick test for Plasmodium falciparum in pediatric patients.
  • To determine the sensitivity and limitations of Parasight-F in a pediatric population.

Main Methods:

  • A study involving 30 children (2 months to 12 years) with confirmed Plasmodium falciparum on peripheral smear.
  • Parasight-F testing performed on EDTA or finger-prick blood samples.
  • Analysis of sensitivity based on infection type (mono vs. mixed) and patient age.

Main Results:

  • Parasight-F demonstrated an overall sensitivity of 83.3% for Plasmodium falciparum detection.
  • Sensitivity dropped to 25% in cases of mixed Plasmodium vivax and falciparum infections.
  • All infants under 6 months tested negative with Parasight-F.
  • Parasitic index, prior antimalarial treatment, and malaria severity did not impact test sensitivity.

Conclusions:

  • Parasight-F is a valuable tool for diagnosing Plasmodium falciparum malaria in children.
  • Clinicians should be aware of the reduced sensitivity in mixed infections and in very young children.
  • Further research may be needed to improve RDT performance in specific pediatric subgroups.